BRUNELLO, Nicoletta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.128
EU - Europa 7.480
AS - Asia 6.539
SA - Sud America 1.100
AF - Africa 107
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 9
Totale 30.393
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.933
SG - Singapore 2.453
GB - Regno Unito 2.050
CN - Cina 1.740
DE - Germania 1.659
IT - Italia 1.249
HK - Hong Kong 1.166
BR - Brasile 953
SE - Svezia 707
RU - Federazione Russa 551
VN - Vietnam 297
FI - Finlandia 252
UA - Ucraina 229
TR - Turchia 192
BG - Bulgaria 168
IN - India 148
KR - Corea 141
FR - Francia 136
CA - Canada 131
IE - Irlanda 93
ID - Indonesia 84
JP - Giappone 75
NL - Olanda 73
PL - Polonia 65
AR - Argentina 59
ES - Italia 50
MX - Messico 43
BD - Bangladesh 39
ZA - Sudafrica 34
CH - Svizzera 33
BE - Belgio 28
CZ - Repubblica Ceca 28
AU - Australia 27
EC - Ecuador 25
AE - Emirati Arabi Uniti 23
RO - Romania 22
IQ - Iraq 21
PK - Pakistan 21
EG - Egitto 19
LT - Lituania 19
AT - Austria 17
IR - Iran 15
MA - Marocco 15
UZ - Uzbekistan 15
CO - Colombia 13
TH - Thailandia 13
TW - Taiwan 13
VE - Venezuela 11
CL - Cile 10
JO - Giordania 10
PY - Paraguay 10
SA - Arabia Saudita 10
IL - Israele 9
PH - Filippine 9
DZ - Algeria 8
GR - Grecia 8
UY - Uruguay 8
AZ - Azerbaigian 7
DK - Danimarca 7
KE - Kenya 7
KZ - Kazakistan 7
MY - Malesia 7
PE - Perù 7
TN - Tunisia 7
SI - Slovenia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
HU - Ungheria 5
BO - Bolivia 4
ET - Etiopia 4
MD - Moldavia 4
EU - Europa 3
JM - Giamaica 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AN - Antille olandesi 2
BB - Barbados 2
BY - Bielorussia 2
BZ - Belize 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
MK - Macedonia 2
PA - Panama 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
Totale 30.369
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.594
Fairfield 1.580
Southend 1.265
Ashburn 1.240
Hong Kong 1.150
Singapore 1.111
Chandler 1.038
Woodbridge 831
Houston 664
Wilmington 568
Hefei 514
Cambridge 484
Seattle 459
Jacksonville 435
London 435
Nyköping 407
Los Angeles 345
Ann Arbor 328
Dearborn 326
Chicago 318
Modena 303
Beijing 276
San Diego 217
Princeton 187
Sofia 167
Helsinki 151
New York 142
Munich 137
Salt Lake City 125
The Dalles 125
Seoul 120
Ho Chi Minh City 104
Moscow 103
Buffalo 91
Dublin 91
Columbus 80
Council Bluffs 80
Eugene 77
São Paulo 72
Shanghai 71
Izmir 67
Milan 67
Hanoi 65
Jakarta 65
Tampa 65
Elk Grove Village 62
Des Moines 57
Rome 56
Bologna 49
Tokyo 49
Falls Church 48
Dallas 47
Warsaw 46
Fremont 45
Redondo Beach 41
Redwood City 41
Istanbul 40
Guangzhou 39
Reggio Emilia 39
Lancaster 37
Norwalk 37
Toronto 35
Rio de Janeiro 34
Frankfurt am Main 33
Parma 33
Phoenix 32
Pittsburgh 31
Montreal 30
Atlanta 29
San Francisco 29
Denver 28
Bremen 27
Brooklyn 26
Sterling 26
Turku 26
Belo Horizonte 25
Johannesburg 25
Brasília 24
Miami 24
Brno 23
Nanjing 23
San Mateo 23
Boardman 22
Brussels 22
Catania 22
Chennai 22
Roorkee 22
Stockholm 22
Kent 21
Poplar 21
Boston 20
Kilburn 20
Hounslow 19
Amsterdam 18
Vancouver 18
Paris 17
Wuhan 17
Detroit 16
Carpi 15
Curitiba 15
Totale 19.808
Salva come PNG Salva come JPEG
Nome #
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 533
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 446
Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders 436
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression 433
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 414
N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons. 396
Early postnatal chronic inflammation produces long-term changes in pain behavior and N-methyl-D-aspartate receptor subtype gene expression in the central nervous system of adult mice 378
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 377
Disease-induced neuroinflammation and depression 369
Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus 366
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 352
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study 351
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in a rat model of depression 350
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 341
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 338
Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK alpha and CaMKK beta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor 335
Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment 331
Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression 329
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 319
Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). . 318
Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 318
Interferon alpha exposure increases the expression of the enzymes belonging to the kynurenine pathway in an in vitro model of human neurons: SH-SY5Y cells 308
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 306
Behavioural and molecular effects of the combined treatment fluoxetine plus acetylsalicylic acid in a rat model of depression 304
Neonatal persistent inflammation alters pain response and NMDA receptor expression in adult mice 289
P.2.a.012 Co-administration of fluoxetine with acetylsalicylic acid, but not flurbiprofen or celecoxib, for one week shows an antidepressant-like effect 288
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. 287
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 287
Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells 286
Erratum to: Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 (J Neuroimmune Pharmacol, 2015, DOI 10.1007/s11481-015-9641-x) 286
Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. 285
Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure 284
Molecular changes associated with escitalopram response in a stress-based model of depression 281
Hypothalamic expression of inflammatory mediators in an animal model of binge eating 280
Effects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depression 279
Lymnaea stagnalis as model for translational neuroscience research: from pond to bench 275
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 272
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 267
Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment 267
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine 267
Interferon-alpha exposure increases the expression of enzymes of the kynurenine pathway and induces apoptosis in a model of human neurons 261
ADOLESCENCE AS A CRITICAL TIME-WINDOW FOR NEUROINFLAMMATION IN THE MOUSE: WHY SEX MATTERS 252
Gene expression profile of the hippocampus of a behavioural model of depression 251
Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depressio 250
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 250
Cloning of mouse Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKKbeta) and characterization of CaMKKbeta and CaMKKalpha distribution in the adult mouse brain. 248
Restraint stress increases the expression of brain derived neurotrophic factor in the hippocampus of a mouse model of depression 247
Modulation of neuroplasticity-related targets following stress-induced acute escape deficit 245
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 242
Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain 241
Environmental quality modulates the endocannabinoid system along the gut-brain axis in a mouse model of LPS-induced neuroinflammation 240
Mood stabilizers: protecting the mood ... protecting the brain 240
New combination therapies from animal to human 238
HTR1B as a risk profile maker in psychiatric disorders:a review through motivation and memory 237
Regulation of CREB function in rat frontal cortex after combined treatment with Fluoxetine and Olanzapine 236
Deciphering the central immunomodulatory effects of a vortioxetine pretreatment on the LPS-induced inflammatory cascade 228
Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus 227
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 226
Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression 224
Cyclic GMP inhibition of metabotropic glutamate receptor-induced phosphoinositide hydrolysis in mesencephalic neurons 223
Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases 223
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression 218
Vortioxetine Prevents Lipopolysaccharide-Induced Memory Impairment Without Inhibiting the Initial Inflammatory Cascade 218
Environmental enrichment influences mouse hippocampal neuroinflammatory response 213
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 212
Dysbindin, D3 receptors, and their genetic interaction differently regulate neuroplasticity genes in the mouse brain 206
Metabolic changes induced by interferon-α exposure in an in vitro model of human neurons 203
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas 200
Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress 200
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 193
Effect of idebenone on in vivo serotonin release and serotonergic receptors in young and aged rats 191
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment 190
Practical issues in clinical research of schizophrenia 187
Metabolic characterization of SH-SY5Y cells and effects of interferon-alpha exposure 187
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment 187
cAMP-dependent binding proteins and endogenous phosphorylation after antidepressant treatment 187
VORTIOXETINE ATTENUATES NEUROINFLAMMATION BY MODULATING THE NOD-LIKE RECEPTOR FAMILY PYRIN DOMAIN CONTAINING 3 INFLAMMASOME ACTIVATION IN MICROGLIA: IMPLICATIONS FOR COGNITIVE FUNCTION 185
cAMP-dependent phosphorylation system after short and long-term administration of moclobemide 184
Interplay between inflammation and neural plasticity: Both immune activation and suppression impair LTP and BDNF expression 178
cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity 175
Chiralità e farmaci antidepressivi 170
Serum metabolic signature of binge-like palatable food consumption in female rats by nuclear magnetic resonance spectroscopy 162
P.304 Executive functioning and genetic variation in pediatric patients with cancer 161
New insights into the biology of schizophrenia through the mechanism of action of clozapine. 160
Behavioural and neurochemical changes produced by lefetamine in two inbred strains of mice 158
cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment 156
Second messenger-regulated protein kinases in the brain: Their functional role and the action of antidepressant drugs 155
Identification and characterization of the kynurenine pathway in the pond snail Lymnaea stagnalis 148
Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit NMDA receptor activity and prevent neurotoxicity in mesencephalic neuron in vitro 148
Escitalopram: meccanismo d’azione e profili clinico 146
Farmaci antidepressivi parte II: SNRI e farmaci multimodali 144
Behavioural and biochemical effects in C57BL/6J mice after a prolonged treatment with the δ‐opiate antagonist ICI 154129 140
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: Dissociation from effects on prolactin secretion 140
Hippocampus-related effects of fluoxetine treatment under stressful vs enriched conditions 138
Role of dopamine D3 receptors, dysbindin, and their functional interaction on the expression of key genes for neuroplasticity in the mouse brain 133
BIOCHEMICAL AND MOLECULAR CHANGES IN RAT CEREBRAL CORTEX AFTER CHRONIC ANTIDEPRESSANT TREATMENT: ‘IN VITRO AND’‘IN VIVO’ STUDIES 129
Age‐Related Changes in Rat Serotonergic and Adrenergic Systems and in Receptor Responsiveness to Subchronic Desipramine Treatment 126
Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine 125
Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies 124
Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: Interactions with reserpine 123
Totale 24.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.559 0 0 0 0 0 232 205 288 174 311 218 131
2021/20223.346 478 258 153 241 75 233 113 137 307 351 686 314
2022/20232.866 303 255 250 293 289 441 43 307 424 28 116 117
2023/20241.987 130 127 130 222 379 157 101 278 38 101 90 234
2024/20257.626 290 98 101 490 1.278 1.074 466 378 793 986 868 804
2025/20265.715 790 401 904 1.399 2.069 152 0 0 0 0 0 0
Totale 30.725